Lv1
28 积分 2022-12-28 加入
Post-progression treatment options after CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer
1个月前
已完结
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
1个月前
已完结
Prognostic Factors for Persistent or Recurrent Disease of Papillary Thyroid Carcinoma with Neck Lymph Node Metastases and/or Tumor Extension beyond the Thyroid Capsule at Initial Diagnosis
5个月前
已完结
Assessment and Influencing Factors of Post‐Competency Among Nursing Master’s Degree Graduates in China: A Multivariate Analysis Approach
5个月前
已完结
Tumor-associated Schwann cell remodeling under metabolic stress via lactate sensing orchestrates pancreatic ductal adenocarcinoma development
5个月前
已完结
Near-death experience in survivors of cardiac arrest: a prospective study in the Netherlands
5个月前
已完结
RNA modification systems as therapeutic targets
5个月前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
5个月前
已完结
Drug resistance in breast cancer: Mechanisms and strategies for management
5个月前
已完结
Epitranscriptomic control of cancer hallmarks: Functions, mechanisms, and therapeutics of RNA modifications
5个月前
已完结
皖公网安备34019202002308
